Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Is Zoetis Inc. (ZTS) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
ThePrint on MSN1d
Top pharma alliance refutes ‘ill-researched’ US study linking Indian generics to higher adverse events
Indian Pharmaceutical Alliance says the study relies on FDA Adverse Event Reporting System data, which captures link between ...
Analytics Insight2d
Sun Pharma Shares Gain 2.50% to ₹1,651.80 Amid US Oncology Company Acquisition
Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the ...
Forbes India1d
How acquisitions turned out to be Sun Pharma's winning strategy
The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...
Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Dr. David Weldon on the Withdrawal
Artificial Dyes in Food: In his first meeting with top executives from PepsiCo, W.K. Kellogg, General Mills and other large ...
The Financial Express2d
Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating
Sun Pharma surges 3% on Checkpoint Therapeutics acquisition; Motilal Oswal maintains 'Buy' with 22% upside potential. Read ...
Nevada pediatricians urge measles vaccinations as cases rise across the US
Pediatricians at Renown Children’s Hospital are urging parents to vaccinate their children against measles amid a rise in cases across the United States.As of ...
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details
Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC.